HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vanishing White Matter Leukodystrophy with Ovarian Failure

Also Known As:
Ovarioleukodystrophy
Networked: 8 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Related Diseases

1. Leukoencephalopathies
2. Ataxia (Dyssynergia)
3. Cognitive Dysfunction
4. Cerebellar Ataxia (Dysmetria)

Experts

1. Schiffmann, Raphael: 3 articles (02/2008 - 07/2004)
2. Boespflug-Tanguy, Odile: 2 articles (10/2004 - 07/2004)
3. Fogli, Anne: 2 articles (10/2004 - 07/2004)
4. Antonellis, Anthony: 1 article (02/2020)
5. Kuo, Molly E: 1 article (02/2020)
6. Shakkottai, Vikram G: 1 article (02/2020)
7. Faulkner, H J: 1 article (12/2016)
8. Ibitoye, R T: 1 article (12/2016)
9. Renowden, S A: 1 article (12/2016)
10. Rice, C M: 1 article (12/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Vanishing White Matter Leukodystrophy with Ovarian Failure:
1. Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA
2. Peptide Initiation Factors (Initiation Factor)IBA
3. Alanine-tRNA LigaseIBA